- Location
genetic mutation
"-
Google Has Lengthened Its Leap Into Medtech by Acquiring Lift Labs
Sep 16, 2014Google has lengthened its leap into medtech by acquiring Lift Labs, a San Francisco startup that makes a spoon to help prevent patients with movement disorders from spilling their food. The Internet giant will fold Lift Labs into Google ...
Tags: movement disorders, spoon
-
Valproic Acid Is One of The Most Widely Prescribed Drugs for The Treatment of Epilepsy
Feb 18, 2014Valproic acid is one of the most widely prescribed drugs for the treatment of epilepsy. It has also been shown to be effective for the treatment of mood disorders and migraine headaches. What prompted your research into valproic acid ...
Tags: Valproic Acid, Health, Medicine
-
Most Health Insurance Companies Will Cover Drugs That Help Prevent Breast Cancer for Free
Jan 13, 2014U.S. government officials say under the Affordable Care Act most health insurance companies will cover drugs that help prevent breast cancer for free. Kathleen Sebelius, secretary for the U.S. Department of Health and Human Services, and ...
-
Secretary of State Donald Rumsfeld Made a Statement Regarding Weapons of Mass Destruction
Jan 3, 2014In 2002, Secretary of state Donald Rumsfeld made a statement regarding weapons of mass destruction that today is still well known. He famously parsed the evidence (or lack thereof) into "known knowns, known unknowns, and unknown unknowns." ...
Tags: weapons of mass destruction, evolutionary biology, Donald Rumsfeld
-
A Genetic Mutation Associated with an Increased Risk of Heart Disease Is Common in African
Dec 27, 2013A genetic mutation associated with an increased risk of heart disease, type 2 diabetes and other health problems is common in Africans and people of African descent worldwide, according to a new study. The findings may help explain why ...
Tags: cgenetic mutation, genetic mutation, diabetes, ApoE gene, African
-
FDA 510(K) Approval for Breast Cancer Image Analysis Algorithm Is Obtained by Ventana
Dec 9, 2013Ventana Medical Systems, a member of the Roche Group, has obtained the US Food and Drug Administration’s (FDA) 510(k) approval for its Companion Algorithm ER (SP1) image analysis algorithm used with the Ventana iScan Coreo scanner ...
Tags: Breast Cancer, Analysis Algorithm
-
BBRF Has Announced The Latest Recipients of Its Narsad Distinguished Investigator Grants
Nov 12, 2013The Brain & Behavior Research Foundation (BBRF) (formerly known as NARSAD, the National Alliance for Research on Schizophrenia and Depression), under the direction of president and CEO Dr Jeffrey Borenstein, has announced the latest ...
Tags: Narsad, BBRF, investigator, award
-
Finnish Drug Maker Biohit Oyj Will Reportedly Launch Patent Drug Acetuim
May 14, 2013Finnish drug maker Biohit Oyj will reportedly launch patent drug Acetuim that could control blastomogen acetaldehyde, which is oriented to the Chinese market, revealed the CEO of the company Semi Korpela. Biohit Oyj is currently ...
Tags: Stomach Medicine, Medicine
-
DART Therapeutics Is Developing a Selective Androgen Receptor Modulator Drug Candidate
Mar 21, 2013US-based biotechnology firm DART Therapeutics is developing a selective androgen receptor modulator (SARM) drug candidate for Duchenne muscular dystrophy (DMD). DMD is a pediatric rare disease that affects approximately one in 3,600 boys ...
-
European Commission Has Approved Vertex Pharmaceuticals's Kalydeco
Jul 30, 2012The European Commission has approved Vertex Pharmaceuticals' Kalydeco (ivacaftor) to treat the underlying cause of cystic fibrosis in people with a specific genetic mutation (G551D). The approval is based on positive findings from two ...
Tags: european approval, kalydeco, cystic fibrosis
-
CHMP Has Issued a Positive Opinion
May 28, 2012The European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Vertex Pharmaceuticals' Kalydeco (ivacaftor) to treat the underlying cause of cystic fibrosis (CF). Kalydeco is indicated for people ...
Tags: Kalydeco, cystic fibrosis, clinical study
